Trademark: 79209626
Word
NEUROBLOOD
Status
Dead
Status Code
600
Status Date
Sunday, June 24, 2018
Serial Number
79209626
Mark Type
5000
Filing Date
Wednesday, March 15, 2017
Abandoned Date
Friday, December 29, 2017

Trademark Owner History

Classifications
5 Pharmaceutical preparations for the prevention of Alzheimer, Parkinson diseases, amyotrophic lateral sclerosis, frontotemporal dementia, progressive supranuclear palsy and other neurodegenerative diseases; veterinary preparations of prevention and monitoring of neurodegenerative illnesses in animal models, namely dogs, cats, mice, rats, monkeys; sanitary preparations for medical purposes use for the prevention of Alzheimer, Parkinson diseases, amyotrophic lateral sclerosis, frontotemporal dementia, progressive supranuclear palsy and other neurodegenerative diseases; chemical preparations for medical use for the prevention of Alzheimer, Parkinson diseases, amyotrophic lateral sclerosis, frontotemporal dementia, progressive supranuclear palsy and other neurodegenerative diseases; chemical preparations for pharmaceutical use for the prevention of Alzheimer, Parkinson diseases, amyotrophic lateral sclerosis, frontotemporal dementia, progressive supranuclear palsy and other neurodegenerative diseases
9 Scientific apparatus and analytical instruments namely, instruments dedicated to separation of biomolecules such as High Performance Liquid Chromatography, Electrophoresis, Capillary Electrophoresis, Mass Spectrometry, Infrared Spectrometry, RAMAN Spectrometry, spectroscopy, DNA-Sequencer , RNA-Sequencer, Lab on chip, DNA-microarray, RNA-microarray; Measuring apparatus and instruments used for measuring biomarkers in biological liquids, blood samples such as free or labelled monoamines, derivates of monoamines, Red-Ox forms of monoamines subsequently detected by Laser induced fluorescence detection or Electrochemical detection; signaling apparatus and instruments namely such as High Performance Liquid Chromatography, Electrophoresis, Capillary Electrophoresis, Mass Spectrometry, Infrared Spectrometry, RAMAN Spectrometry, spectroscopy, DNA-Sequencer , RNA-Sequencer, lab on chip, DNA-microarray, RNA-microarray; software screening, monitoring, revealing of mental illnesses, including learning disabilities and Alzheimer's disease, Parkinson diseases, amyotrophic lateral sclerosis, frontotemporal dementia, progressive supranuclear palsy, other neurodegenerative diseases, and aggregating, analyzing, and reporting of blood tests results; detectors namely, Electrochemical, spectrometry spectroscopy, diode array, photo multiplicator
Color is not claimed as a feature of the mark.
NEURO BLOOD

Trademark Events
Jul 12, 2019
Final Decision Transaction Processed By Ib
Jun 24, 2019
Final Disposition Notice Sent To Ib
Jun 24, 2019
Final Disposition Notice Created, To Be Sent To Ib
Nov 30, 2018
Notification Of Possible Opposition - Processed By Ib
Nov 14, 2018
Notification Of Possible Opposition Sent To Ib
Nov 14, 2018
Notification Of Possible Opposition Created, To Be Sent To Ib
Jun 25, 2018
Abandonment Notice Mailed - Incomplete Response
Jun 24, 2018
Abandonment - Incomplete Response
Jan 5, 2018
Notice Of Unresponsive Amendment - Mailed
Jan 4, 2018
Report Unresponsive Amendment - Completed
Dec 14, 2017
Teas/Email Correspondence Entered
Dec 14, 2017
Correspondence Received In Law Office
Dec 14, 2017
Teas Response To Office Action Received
Jul 14, 2017
Refusal Processed By Ib
Jun 28, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Jun 28, 2017
Refusal Processed By Mpu
Jun 20, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Jun 19, 2017
Non-Final Action Written
Jun 16, 2017
Application Filing Receipt Mailed
Jun 12, 2017
Assigned To Examiner
Jun 12, 2017
New Application Office Supplied Data Entered In Tram
Jun 8, 2017
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24